253 related articles for article (PubMed ID: 21337372)
1. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis.
Miyazaki K; Ohta Y; Nagai M; Morimoto N; Kurata T; Takehisa Y; Ikeda Y; Matsuura T; Abe K
J Neurosci Res; 2011 May; 89(5):718-28. PubMed ID: 21337372
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.
Garbuzova-Davis S; Haller E; Saporta S; Kolomey I; Nicosia SV; Sanberg PR
Brain Res; 2007 Jul; 1157():126-37. PubMed ID: 17512910
[TBL] [Abstract][Full Text] [Related]
3. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis.
Sasaki S
Neuropathology; 2015 Dec; 35(6):518-28. PubMed ID: 26242689
[TBL] [Abstract][Full Text] [Related]
5. Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.
Ezzi SA; Larivière R; Urushitani M; Julien JP
J Neurochem; 2010 Dec; 115(5):1102-11. PubMed ID: 20807312
[TBL] [Abstract][Full Text] [Related]
6. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement.
Pullen AH; Demestre M; Howard RS; Orrell RW
Acta Neuropathol; 2004 Jan; 107(1):35-46. PubMed ID: 14551798
[TBL] [Abstract][Full Text] [Related]
8. Neurovascular aspects of amyotrophic lateral sclerosis.
Rodrigues MC; Hernandez-Ontiveros DG; Louis MK; Willing AE; Borlongan CV; Sanberg PR; Voltarelli JC; Garbuzova-Davis S
Int Rev Neurobiol; 2012; 102():91-106. PubMed ID: 22748827
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis: a neurovascular disease.
Garbuzova-Davis S; Rodrigues MC; Hernandez-Ontiveros DG; Louis MK; Willing AE; Borlongan CV; Sanberg PR
Brain Res; 2011 Jun; 1398():113-25. PubMed ID: 21632035
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
13. A possible haemodynamic mechanism for amyotrophic lateral sclerosis.
Arhart RW
Med Hypotheses; 2010 Oct; 75(4):341-6. PubMed ID: 20400230
[TBL] [Abstract][Full Text] [Related]
14. [A clinicopathological study of familial amyotrophic lateral sclerosis with special reference to the mode of motoneuron loss in the spinal ventral horn].
Terao S; Sobue G; Mukai E; Murakami N; Hashizume Y
Rinsho Shinkeigaku; 1991 Sep; 31(9):960-9. PubMed ID: 1769159
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.
Lewandowski SA; Nilsson I; Fredriksson L; Lönnerberg P; Muhl L; Zeitelhofer M; Adzemovic MZ; Nichterwitz S; Lawrence DA; Hedlund E; Eriksson U
Acta Neuropathol; 2016 Mar; 131(3):453-64. PubMed ID: 26687981
[TBL] [Abstract][Full Text] [Related]
16. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
Schaefer AM; Sanes JR; Lichtman JW
J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
18. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
[TBL] [Abstract][Full Text] [Related]
19. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F
Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893
[TBL] [Abstract][Full Text] [Related]
20. Impaired blood-brain/spinal cord barrier in ALS patients.
Garbuzova-Davis S; Hernandez-Ontiveros DG; Rodrigues MC; Haller E; Frisina-Deyo A; Mirtyl S; Sallot S; Saporta S; Borlongan CV; Sanberg PR
Brain Res; 2012 Aug; 1469():114-28. PubMed ID: 22750125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
